Quanterix
In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More
News items for the week of May 16, 2022.
Quanterix Q1 Revenues up 9 Percent
The company posted Q1 2022 revenues of $29.6 million, up from $27.2 million in Q1 2021 and above the consensus Wall Street estimate of $29.1 million.
Stocks of Omics Tools, MDx Firms Find More Stable Footing in February After Tough Start to Year
The GenomeWeb Top 40 was flat during February while the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index posted modest declines.
Quanterix Q4 Revenues Rise 16 Percent
The company posted Q4 revenues of $30.3 million, up from $26.1 million in Q4 2020, and beat the consensus Wall Street estimate of $28.5 million.
Jan 13, 2022
Quanterix Projects Q4 2021 Revenues of $29M to $31M
Aug 5, 2021
Quanterix Revenues Almost Double in Q2
May 5, 2021
Quanterix Q1 Revenues up 73 Percent
Mar 10, 2021
Mar 2, 2021
Quanterix Q4 Revenues Up 64 Percent
Feb 12, 2021
Quanterix, WuXi AppTec to Open Joint Lab in Shanghai
Feb 4, 2021
Quanterix Prices $250M Public Stock Offering
Aug 7, 2020